Weichselbaum R R, Greenberger J S, Schmidt A, Karpas A, Moloney W C, Little J B
Radiology. 1981 May;139(2):485-7. doi: 10.1148/radiology.139.2.6939019.
The in vitro radiobiologic survival values (n, D0) of four tumor lines derived from human hematopoietic tumors were studied. These cell lines were HL50 (n = 1.3, D0 = 117 rad[1.17 Gy]), promyelocytic leukemia; K562 (n = 1.4, D0 = 165 rad[1.65 Gy]), erythroleukemia; 45 (n = 1.1, D0 = 147 rad[1.47 Gy]), acute lymphocyte leukemia; and 176 (n = 4.0, D0 = 76 rad[0.76 Gy]), acute monomyelogenous leukemia. More cell lines must be examined before the exact relationship between in vitro radiosensitivity and clinical radiocurability is firmly established.
对源自人类造血肿瘤的四种肿瘤细胞系的体外放射生物学存活值(n,D0)进行了研究。这些细胞系分别是HL50(n = 1.3,D0 = 117拉德[1.17戈瑞]),早幼粒细胞白血病;K562(n = 1.4,D0 = 165拉德[1.65戈瑞]),红白血病;45(n = 1.1,D0 = 147拉德[1.47戈瑞]),急性淋巴细胞白血病;以及176(n = 4.0,D0 = 76拉德[0.76戈瑞]),急性单核细胞白血病。在体外放射敏感性与临床放射可治愈性之间的确切关系被牢固确立之前,必须检查更多的细胞系。